| Autor: |
Levin JM; Ovid Therapeutics, Inc, New York, NY, USA.; Biotechnology Innovation Organization (BIO), Washington, DC, USA., Oprea TI; Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.; Autophagy Inflammation and Metabolism Center of Biomedical Research Excellence, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Davidovich S; SparkBeyond, Netanya, Israel., Clozel T; Owkin, Paris, France., Overington JP; Medicines Discovery Catapult, Cheshire, UK., Vanhaelen Q; Insilico Medicine, Hong Kong Science and Technology Park, Hong Kong, China., Cantor CR; Retrotope, Inc, Los Altos, CA, USA., Bischof E; Insilico Medicine, Hong Kong Science and Technology Park, Hong Kong, China. bischofevelyne@gmail.com.; Shanghai University of Medicine and Health Sciences, College of Clinical Medicine, Shanghai, China. bischofevelyne@gmail.com.; Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy. bischofevelyne@gmail.com., Zhavoronkov A; Insilico Medicine, Hong Kong Science and Technology Park, Hong Kong, China. alex@insilico.com. |
Full text from SpringerLink